节点文献

心肝宝治疗晚期血吸虫病肝纤维化的临床研究

OBSERVATIONS ON XINGANBAO THERAPY OF LIVER FIBROSIS CAUSED BY ADVANCED SCHISTOSOMIASIS

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 钱燕喃周明华尚国光魏宝茹华海涌王德威刘铭堂贺国铭刘伯荧赵伯阳

【Author】 Qian Yannan Zhou Minghua Shang Guoguang et al Director.Jing Weixin Jiangsu Institute of Parasitic Diseases

【机构】 江苏省血吸虫病防治研究所昆山市血防站泰兴县卫生防疫站武进县卫生防疫站江苏省血防办公室江苏省血防办公室

【摘要】 用心肝宝胶囊治疗晚期血吸虫病肝纤维化病人106例。男性58例(54.72%),女性48例(45.28%)。每例均有门静脉高压的诊断依据。每d剂量为2.25g(250mg/粒),分3次口服,连续2个月。结果能使患者症状减轻或消除,肝功能好转,血清白蛋白上升,Y球蛋白下降;免疫功能得到调整;门、脾静脉内径缩小。显效者15例(14.15%),有效80例(75.47%),总有效率为89.62%。

【Abstract】 106 patients with liver fibrosis, 58 men (54.72%) and 48 women (45.28%), were treated with Xinganbao. All of these cases were diagnosed as portal hypertension of advanced schistosomiasis. The drug was given in a daily dose of 2.25g (250mg/capsule) 3 times a day for a succession of 2 months.The result of our study suggests that Xinganbao therapy can relieve and/or eliminate the clinical symptoms of advanced schistosomiasis with liver function recovered, serum albumin raised, γ-globulin decreased, immune function adjusted and caliber of portal and spleen vein much diminished. The total rate of efficacy was 89.62%, of which, 14.15% (15 cases) markedly improved while 75.47% (80 cases) moderately.

  • 【文献出处】 中国血吸虫病防治杂志 ,Chinese Journal of Schistosomiasis Control , 编辑部邮箱 ,1991年05期
  • 【被引频次】8
  • 【下载频次】39
节点文献中: 

本文链接的文献网络图示:

本文的引文网络